Cargando…

The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2

The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group II coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenhui, Sui, Jianhua, Huang, I-Chueh, Kuhn, Jens H., Radoshitzky, Sheli R., Marasco, Wayne A., Choe, Hyeryun, Farzan, Michael
Formato: Texto
Lenguaje:English
Publicado: Elsevier Inc. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693060/
https://www.ncbi.nlm.nih.gov/pubmed/17631932
http://dx.doi.org/10.1016/j.virol.2007.04.035
_version_ 1782167944351973376
author Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
author_facet Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
author_sort Li, Wenhui
collection PubMed
description The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group II coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by β-strands 4 and 5.
format Text
id pubmed-2693060
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-26930602009-06-08 The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2 Li, Wenhui Sui, Jianhua Huang, I-Chueh Kuhn, Jens H. Radoshitzky, Sheli R. Marasco, Wayne A. Choe, Hyeryun Farzan, Michael Virology Article The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group II coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by β-strands 4 and 5. Elsevier Inc. 2007-10-25 2007-07-12 /pmc/articles/PMC2693060/ /pubmed/17631932 http://dx.doi.org/10.1016/j.virol.2007.04.035 Text en Copyright © 2007 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title_full The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title_fullStr The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title_full_unstemmed The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title_short The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
title_sort s proteins of human coronavirus nl63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ace2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693060/
https://www.ncbi.nlm.nih.gov/pubmed/17631932
http://dx.doi.org/10.1016/j.virol.2007.04.035
work_keys_str_mv AT liwenhui thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT suijianhua thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT huangichueh thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT kuhnjensh thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT radoshitzkyshelir thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT marascowaynea thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT choehyeryun thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT farzanmichael thesproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT liwenhui sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT suijianhua sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT huangichueh sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT kuhnjensh sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT radoshitzkyshelir sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT marascowaynea sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT choehyeryun sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2
AT farzanmichael sproteinsofhumancoronavirusnl63andsevereacuterespiratorysyndromecoronavirusbindoverlappingregionsoface2